Scientists hunt for clues in blood to predict dangerous drug reactions
NCT ID NCT03409016
Summary
This study aims to find signs in the blood that might predict which cancer patients will experience serious side effects from a newer type of drug called immune checkpoint inhibitors. It involves 69 adults with metastatic cancer who are starting either this immunotherapy or standard chemotherapy. The research only involves taking blood samples at four time points to look for these predictive markers, with no experimental treatments given.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Colorado Denver
Aurora, Colorado, 80045, United States
Conditions
Explore the condition pages connected to this study.